I think fusion is more advanced with their lead therapy asset.
it depends whether you consider most value is to therapy or imaging. Seems Wilsons discounts imaging value significantly
Research/Valuation, page-201
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.02 |
Change
-0.070(1.71%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $4.10 | $4.12 | $3.96 | $2.113M | 527.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 153 | $4.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.03 | 1280 | 1 |
View Market Depth
| Last trade - 12.26pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.04 |
Change
-0.070 ( 1.35 %) |
||||
| Open | High | Low | Volume | ||
| $4.12 | $4.12 | $3.96 | 24451 | ||
| Last updated 12.34pm 22/05/2024 ? | |||||
| CU6 (ASX) Chart |